New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
12:05 EDTNDAQ, HEK, NVO, SNY, REGN, GOOG, HD, BBRY, AAPL, GMCROn The Fly: Midday Wrap
Stocks on Wall Street were slightly lower at midday with the averages moving in a narrow range as earnings season nears a close... ECONOMIC EVENTS: In the U.S., no major economic data was reported. In Europe, a meeting of finance ministers of the countries using the euro convened, with the strength of the shared currency, how to handle a bailout for Cyprus and progress in Greece likely to be discussed. In Asia, Chinese and Japanese markets were closed for holidays... COMPANY NEWS: Google (GOOG) slid about 1% after Chairman Eric Schmidt disclosed plans to sell 3.2M of the shares he holds, valued at $2.5B... Apple (AAPL) iPhones will replace Blackberry (BBRY) handsets for Home Depot (HD) managers and corporate staffers, according to a blog report. Shares of Apple rose nearly 2% amid that and the usual torrent of other news surrounding the world's biggest tech company, including rumors of a new "iWatch" that is under development. Its strength may have also been related to continued speculation around what, if anything, CEO Tim Cook may announce tomorrow in terms of plans to return capital to shareholders... MAJOR MOVERS: Among the notable gainers was Nasdaq (NDAQ), which jumped over 5% after Charles Gasparino of Fox Business said the company held "going private" talks with Carlyle Group (CG) that broke down but may resume. Also higher was Regeneron (REGN), which rose 4% after it disclosed that its partner Sanofi (SNY) plans to raises its stake by purchasing Regeneron shares. Sanofi was also higher by 3%, but that may have had more to do with the FDA directing Novo Nordisk (NVO) to carry out a new study on its competing insulin product prior to U.S. approval. Novo Nordisk shares fell 14% following the FDA decision. Also lower were shares of Heckmann (HEK), which declined 8% following a downgrade at Wedbush, and Green Mountain (GMCR), which slid 4% after a downgrade at Dougherty... INDICES: Near noon, the Dow was down 17.32, or 0.12%, to 13,975.65; the Nasdaq was down 2.60, or 0.08%, to 3,191.27; and the S&P 500 was down 0.65, or 0.04%, to 1,517.28.
News For NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR From The Last 14 Days
Check below for free stories on NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | all recent news | >>
September 3, 2014
16:01 EDTAAPLOptions Update; September 3, 2014
Subscribe for More Information
14:33 EDTHDHome Depot data breach involves nearly all U.S. stores, Krebs reports
Subscribe for More Information
13:33 EDTAAPLGT Advanced September volatility elevated into Apple event
Subscribe for More Information
13:02 EDTGOOGAbbVie, Calico announce collaboration
Subscribe for More Information
12:59 EDTAAPLNXP Semiconductors volatility flat as shares near record high into Apple event
NXP Semiconductors overall option implied volatility of 32 is near its 26-week average of 34 according to Track Data, suggesting non-directional price movement.
12:49 EDTSNYSanofi reports Dengue vaccine candidate achieves its phase 3 primary endpoint
Sanofi Pasteur, the vaccines division of Sanofi, announced that the final landmark phase 3 efficacy study of its dengue vaccine candidate in Latin America successfully achieved its primary clinical endpoint. Results showed an overall significant reduction of 60.8% of dengue disease cases in children and adolescents 9-16 years old after a three-dose vaccination schedule. Importantly, efficacy was observed against each of the four dengue serotypes. Additional observations of the results showed a clinically important reduction by 80.3% in the risk of hospitalization due to dengue during the study. The results also showed in the study population an efficacy against dengue haemorrhagic fever, the severe form of dengue, which is consistent with the results released from Sanofi’s phase 3 dengue study in Asia. Lastly, the results suggest better protection in case of prior exposure to dengue.
12:33 EDTAAPLOn The Fly: Midday Wrap
Stocks on Wall Street were higher to begin the day, as reports spurred optimism that a ceasefire agreement between Russia and the Ukraine may soon be reached. The move was short lived, as the averages turned mixed during the second hour of trading. Shares of Apple (AAPL) are weighing down the Nasdaq after an analyst recommended investors take some profits in the stock. ECONOMIC EVENTS: In the U.S., factory orders rose 10.5% in July, which was a bit below the forecast for 11.0% growth. The Fed's Beige Book is scheduled to be released at 2:00 pm ET. In Europe, the final reading of Eurozone services PMI was knocked down to 53.1 from a preliminary 53.5 reading, mirroring the lowering of the Eurozone manufacturing PMI reading yesterday. COMPANY NEWS: Shares of Apple retreated 4% after research firm Pacific Crest advised investors to take some profits in the stock. Pacific Crest analyst Andy Hargreaves forecast the percentage of new iPhone users who buy the next version of the device beyond the iPhone 6 is likely to decline versus prior cycles. The stock likely has only limited room to increase, according to Hargreaves, who said he would probably downgrade Apple unless new products that can generate billions of dollars in new operating profit are launched at its September 9 event... Carmakers reported on August vehicle sales in the U.S., with Chrysler (FIATY) reporting a 20% increase, Ford stating that sales rose slightly compared to the prior year and General Motors (GM) posting a 1.2% decline in sales. MAJOR MOVERS: Among the notable gainers was Infinity Pharmaceuticals (INFI), which jumped 46% after the company announced a cancer drug collaboration with AbbVie (ABBV) and a master clinical supply agreement with Roche (RHHBY). Also higher was Mobileye (MBLY), which gained nearly 10% after Morgan Stanley wrote that the stock could rise "towards $100" if the company maintains its current market, gross margins and earnings position. Mobileye is scheduled to report on its second quarter results tomorrow morning, which will be its first quarterly report since its August IPO. Among the noteworthy losers was Repros Therapeutics (RPRX), which dropped 15% after newly posted FDA briefing documents regarding a panel on T-normalizing therapies prompted Piper Jaffray to downgrade the stock to Neutral from Overweight. Also lower following its earnings report was apparel company Vince Holding (VNCE), which fell 11%. INDEXES: Near midday, the Dow was up 33.71, or 0.2%, to 17,101.27, the Nasdaq was down 23.24, or 0.51%, to 4,574.95, and the S&P 500 was down 0.64, or 0.03%, to 2,001.64.
11:44 EDTAAPLApple breaks support, levels to watch
Subscribe for More Information
11:35 EDTBBRYStocks with call strike movement; BBRY TWTR
Subscribe for More Information
11:24 EDTAAPLApple slumps after analyst advises taking profits
Subscribe for More Information
11:08 EDTGOOGAppeals court upholds Google win in patent suit brought by buySAFE
A district court previously ruled that patent claims asserted by buySAFE were invalid because they cover subject matter ineligible for patenting. An appeals court agreed that the district court’s holding is correct and Google did not infringe. Reference Link
10:40 EDTHD, AAPLAnalyst sees security 'spending frenzy' amid high-profile hacks
Subscribe for More Information
10:27 EDTAAPLApple falls, levels to watch
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA TWTR PBR C GILD NFLX FB BIDU
09:01 EDTGMCRKeurig Green Mountain, Coca-Cola expand agreement to Keurig hot brewing system
Keurig Green Mountain (GMCR) and The Coca Cola Company (KO) have expanded the companies’ innovative partnership to offer select beverages from the portfolio of The Coca Cola Company’s still brands in the Keurig hot brewing system in the United States and Canada. Honest Tea will be the first brand from The Coca Cola Company available in K-Cup® packs. In February 2014, the companies signed a 10-year agreement to collaborate on the development and introduction of The Coca Cola Company's global brand portfolio for use in Keurig’s forthcoming Keurig Cold™ at-home beverage system, available in Keurig’s fiscal year 2015. As part of that agreement Coca-Cola acquired a 10% minority equity position in Keurig and subsequently announced its intention to increase its stake up to 16%.
08:58 EDTAAPLInvestors should take profits in Apple, says Pacific Crest
Subscribe for More Information
08:06 EDTAAPLApple iWallet poses threat to PayPal, says RW Baird
Baird said an Apple (AAPL) mobile payments platform will pose a headline risk to eBay's (EBAY) PayPal. The firm sees it as a particular threat to growth opportunities at point-of-sale, although Baird notes PayPal has a solid start, a strong fraud detection platform, compliance with bank regulators, and accelerating growth in e-commerce payments. The firm has Outperform ratings on both stocks, with a price target of $63 on eBay and a target of $105 on Apple.
07:57 EDTAAPLApple coverage assumed with a Perform at Oppenheimer
Subscribe for More Information
07:05 EDTAAPLNordstrom in talks to be early merchant partner with Apple, Bank Innovation says
Subscribe for More Information
06:23 EDTGOOGGoogle satellite exec Greg Wyler leaves company, sources say, WSJ reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use